Multi-Cancer Early Detection (MCED) of Firefighters
Launched by VINCERE CANCER CENTER · Mar 10, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Multi-Cancer Early Detection (MCED) study, is focused on finding new ways to detect cancer early in firefighters. Researchers are looking at blood and urine tests to see how well they can spot cancer before symptoms appear. This is important because early detection can lead to better treatment outcomes.
To participate in this study, you need to be at least 18 years old and currently working as a firefighter, whether full-time or part-time. You should also be part of Vincere's First Responder Cancer Screening Program and be willing to provide blood and urine samples. It’s important to note that if you have had cancer in the last five years (except for non-melanoma skin cancer), you won’t be eligible. If you join the study, you can expect to help researchers learn more about cancer detection, which may benefit firefighters and others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Currently employed as a firefighter, full-time or part-time
- • Taking part in Vincere's First Responder Cancer Screening Program
- • Able to donate blood and urine sample
- • Able to provide informed consent to participate in the study
- Exclusion Criteria:
- • Deemed medically unfit for sample donation
- • Personal history of cancer in the last 5 years (with the exception of non-melanoma skin cancer)
About Vincere Cancer Center
Vincere Cancer Center is a leading clinical research organization dedicated to advancing cancer treatment through innovative clinical trials and cutting-edge therapies. Committed to enhancing patient outcomes, Vincere Cancer Center collaborates with top-tier researchers and healthcare professionals to explore novel therapeutic approaches and improve existing treatment modalities. With a focus on personalized medicine, the center aims to empower patients by providing access to the latest advancements in cancer care while maintaining the highest standards of safety and ethics in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Patients applied
Trial Officials
Vershalee Shukla, MD
Principal Investigator
Vincere Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials